Authors: | Thoron, L.; Arbit, E. |
Article Title: | Hemostatic changes in patients with brain tumors |
Abstract: | Abnormal hemostasis is a functional property of cancer. Hemostatic abnormalities are common in patients with systemic malignant disease and brain tumors. However, the incidence of thromboembolism is higher in patients with brain tumors than in those with systemic disease. This raises the question of whether or not hemostatic abnormalities found in the blood of the two groups of patients differs, suggesting different pathogeneses. The purpose of this report is to review abnormalities in blood and clinical manifestations of abnormal hemostasis found in brain tumors and cancer patients in an attempt to answer this question. Normal hemostasis, as currently understood, will be considered with an emphasis on features unique to the central nervous system. © 1994 Kluwer Academic Publishers. |
Keywords: | review; cancer radiotherapy; brain tumor; brain neoplasms; neoplasms; thrombocyte; brain cancer; blood clotting disorder; tissue plasminogen activator; partial thromboplastin time; tumor necrosis factor; coagulation; urokinase; hemostasis; interleukin 1; thromboplastin; blood clotting; blood coagulation; fibrinolysis; disseminated intravascular coagulation; von willebrand factor; disseminated intravascular clotting; cancer; human |
Journal Title: | Journal of Neuro-Oncology |
Volume: | 22 |
Issue: | 2 |
ISSN: | 0167-594X |
Publisher: | Springer |
Date Published: | 1994-06-01 |
Start Page: | 87 |
End Page: | 100 |
Language: | English |
DOI: | 10.1007/bf01052885 |
PROVIDER: | scopus |
PUBMED: | 7745471 |
DOI/URL: | |
Notes: | Export Date: 14 January 2019 -- Article -- Source: Scopus |